Immix Biopharma reported net income of -$11.56M for the quarter ended Jun 2026. This income statement covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 3.38M | 3.67M | 13.86M | 13.91M | 13.93M | 13.89M | 13.95M | 16.26M | 19.61M | 19.92M | 26.40M | 27.43M | 27.48M | 27.54M | 27.85M | 28.41M | 33.04M | 32.97M | 53.01M | 71.54M | |||
| Operating items | |||||||||||||||||||||||
| Research & DevelopmentR&D | 0.03M | 0.01M | 0.63M | 0.61M | 0.70M | 2.26M | 1.32M | 2.21M | 2.11M | 3.10M | 3.25M | 2.22M | 4.45M | 1.37M | 1.98M | 3.97M | 4.58M | 5.73M | 5.98M | 5.33M | |||
| Selling, General & AdministrativeSG&A | 0.32M | 0.59M | 0.70M | 0.95M | 0.84M | 1.53M | 1.20M | 1.51M | 2.42M | 2.28M | 2.34M | 2.48M | 2.95M | 3.61M | 2.71M | 2.75M | 3.08M | 5.17M | 4.82M | 7.12M | |||
| Operating ExpensesOpex | 0.35M | 0.60M | 1.33M | 1.56M | 1.53M | 3.79M | 2.52M | 3.72M | 4.52M | 5.38M | 5.59M | 4.70M | 7.39M | 4.99M | 4.68M | 6.72M | 7.66M | 10.89M | 10.80M | 12.46M | |||
| Operating IncomeOp. Inc | -0.35M | -0.60M | -1.33M | -1.56M | -1.53M | -3.79M | -2.52M | -3.72M | -4.52M | -5.38M | -5.59M | -4.70M | -7.39M | -4.99M | -4.68M | -6.72M | -7.66M | -10.89M | -10.80M | -12.46M | |||
| EBIT | -0.35M | -0.60M | -1.33M | -1.56M | -1.53M | -3.79M | -2.52M | -3.72M | -4.52M | -5.38M | -5.59M | -4.70M | -7.39M | -4.99M | -4.68M | -6.72M | -7.66M | -10.89M | -10.80M | -12.46M | |||
| Non-operating items | |||||||||||||||||||||||
| Non Operating Interest Expenses | 0.05M | 0.04M | 388.00 | 109.00 | |||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.03M | 0.13M | 0.19M | 0.23M | 0.27M | 0.31M | 0.26M | 0.19M | 0.15M | 0.10M | 0.08M | 0.22M | 0.72M | 0.91M | |||||||||
| Other Non Operating IncomeOther Non Op Inc. | -22.02M | ||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.05M | -22.16M | -388.00 | -109.00 | 0.03M | 0.13M | 0.19M | 0.23M | 0.27M | 0.31M | 0.26M | 0.19M | 0.15M | 0.10M | 0.08M | 0.22M | 0.72M | 0.91M | |||||
| Net income details | |||||||||||||||||||||||
| EBT | -0.40M | -22.75M | -1.33M | -1.56M | -1.53M | -3.79M | -2.49M | -3.59M | -4.34M | -5.15M | -5.32M | -4.40M | -7.14M | -4.80M | -4.53M | -6.61M | -7.58M | -10.68M | -10.09M | -11.54M | |||
| Tax ProvisionsTaxes | 0.00M | -5.12M | 0.00M | 0.00M | 0.00M | -1.74M | 0.01M | 0.01M | 0.01M | -4.33M | 0.01M | 0.01M | 0.01M | -6.07M | 0.01M | 0.01M | 0.01M | -8.26M | 0.01M | ||||
| Profit After TaxPAT | -0.41M | -22.75M | -1.33M | -1.56M | -1.58M | -3.77M | -2.50M | -3.60M | -4.34M | -5.16M | -5.33M | -4.41M | -7.15M | -4.86M | -4.54M | -6.62M | -7.60M | -10.65M | -10.09M | -11.56M | |||
| Income from Non-Controlling InterestsInc. Minority | -0.02M | -0.02M | -0.06M | -0.07M | -0.07M | -0.01M | |||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -0.40M | -17.63M | -1.33M | -1.56M | -1.54M | -2.05M | -2.50M | -3.60M | -4.34M | -0.82M | -5.33M | -4.41M | -7.15M | 1.27M | -4.54M | -6.62M | -7.59M | -2.41M | -10.09M | -11.56M | |||
| Consolidated Net IncomeConsol Net Inc. | -0.40M | -17.63M | -1.33M | -1.56M | -1.54M | -2.05M | -2.50M | -3.60M | -4.34M | -0.82M | -5.33M | -4.41M | -7.15M | 1.27M | -4.54M | -6.62M | -7.59M | -2.41M | -10.09M | -11.56M | |||
| Income towards Parent CompanyParent Net Inc | -0.40M | -17.63M | -1.33M | -1.56M | -1.54M | -2.05M | -2.50M | -3.60M | -4.34M | -0.82M | -5.33M | -4.41M | -7.15M | 1.27M | -4.54M | -6.62M | -7.59M | -2.41M | -10.09M | -11.56M | |||
| Net Income towards Common StockholdersNet Income | -0.40M | -17.63M | -1.33M | -1.56M | -1.54M | -2.05M | -2.50M | -3.60M | -4.34M | -0.82M | -5.33M | -4.41M | -7.15M | 1.27M | -4.54M | -6.62M | -7.59M | -2.41M | -10.09M | -11.56M | |||
| Additional items | |||||||||||||||||||||||
| EPS (Basic) | -0.12 | -4.80 | -0.10 | -0.11 | -0.11 | -0.15 | -0.18 | -0.24 | -0.23 | -0.05 | -0.23 | -0.15 | -0.24 | 0.04 | -0.15 | -0.22 | -0.24 | -0.07 | -0.18 | -0.18 | |||
| EPS (Diluted) | -0.11 | -0.11 | -0.15 | -0.18 | -0.24 | -0.23 | -0.05 | -0.23 | -0.15 | -0.24 | 0.04 | -0.15 | -0.22 | -0.24 | -0.07 | -0.18 | -0.18 | ||||||
| Shares Outstanding | 3.38M | 3.67M | 13.83M | 13.88M | 13.92M | 13.89M | 13.90M | 15.04M | 18.58M | 17.34M | 23.44M | 28.79M | 29.42M | 28.29M | 29.70M | 29.98M | 31.93M | 32.97M | 55.37M | 63.77M | |||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 13.88M | 13.92M | 13.89M | 13.90M | 15.04M | 18.58M | 17.34M | 23.44M | 28.79M | 29.42M | 28.29M | 29.70M | 29.98M | 31.93M | 32.97M | 55.37M | 63.77M | ||||||
| EBITDA | -0.35M | -0.60M | -1.33M | -1.56M | -1.53M | -3.79M | -2.52M | -3.72M | -4.52M | -5.38M | -5.59M | -4.70M | -7.39M | -4.99M | -4.68M | -6.72M | -7.66M | -10.89M | -10.80M | -12.46M | |||
| Interest ExpensesInt Expense | 0.05M | 0.04M | 388.00 | 109.00 | |||||||||||||||||||
| Tax Rate | -0.33 | 22.52 | -0.12 | -0.11 | -0.11 | 45.89 | -0.21 | -0.18 | -0.16 | 84.07 | -0.17 | -0.23 | -0.16 | 126.42 | -0.22 | -0.13 | -0.10 | 77.40 | -0.12 |